RxDoctor Payments Data

Gruschenka Mojica Sanchez

Baltimore, MDNPI 1215356134

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $625,481 of the $625,941 with a category attached, or 99.9%. Every reported general payment came from a single manufacturer, Roche Molecular Systems, Inc.. 2025 is the largest year on record at $266,196, 2.2 times the $121,957 reported in 2023.

$625,941in general payments, 2019–2025

Across 35 payments — averaging $17,884 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Molecular Systems, Inc.$626K

What the payments were for

  • Speaking & faculty fees$625,481100%
  • Travel & lodging$3550%
  • Food & beverage$1050%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Molecular Systems, Inc.35$625,941

Where these figures come from

Is this you, or does something look wrong? →